Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...

Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs ...

Bariatric surgery increases 1-year acute kidney injury and 10-year nephrolithiasis risks but reduces chronic kidney disease and kidney failure risks compared with no surgery in a Danish registry study ...

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel disease-related outcomes.

Understanding The Initial Investment In Robotic Surgery Getting a robotic surgery system into your operating room isn’t ...